ADMA Biologics, Inc.

NasdaqGM:ADMA 株式レポート

時価総額：US$2.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

ADMA Biologics マネジメント

マネジメント 基準チェック /24

ADMA Biologics'の CEO はAdam Grossmanで、 Jan2007年に任命され、 の在任期間は 17.42年です。 の年間総報酬は$ 6.04Mで、 12.4%給与と87.6%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の1.3%を直接所有しており、その価値は$ 32.12M 。経営陣と取締役会の平均在任期間はそれぞれ1.7年と11.9年です。

主要情報

Adam Grossman

最高経営責任者

US$6.0m

報酬総額

CEO給与比率12.4%
CEO在任期間17.4yrs
CEOの所有権1.3%
経営陣の平均在職期間1.7yrs
取締役会の平均在任期間11.9yrs

経営陣の近況

Recent updates

Is ADMA Biologics, Inc. (NASDAQ:ADMA) Trading At A 43% Discount?

May 30
Is ADMA Biologics, Inc. (NASDAQ:ADMA) Trading At A 43% Discount?

ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next

May 13
ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next

Giving ADMA Biologics A Well-Deserved 'Booyah'

May 12

ADMA Biologics, Inc.'s (NASDAQ:ADMA) Prospects Need A Boost To Lift Shares

May 08
ADMA Biologics, Inc.'s (NASDAQ:ADMA) Prospects Need A Boost To Lift Shares

Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?

Apr 04
Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?

Rising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade)

Apr 03

ADMA Biologics: On A Roll Entering 2024

Jan 19

Is There An Opportunity With ADMA Biologics, Inc.'s (NASDAQ:ADMA) 50% Undervaluation?

Jan 09
Is There An Opportunity With ADMA Biologics, Inc.'s (NASDAQ:ADMA) 50% Undervaluation?

ADMA Biologics, Inc. (NASDAQ:ADMA) Surges 30% Yet Its Low P/S Is No Reason For Excitement

Jan 09
ADMA Biologics, Inc. (NASDAQ:ADMA) Surges 30% Yet Its Low P/S Is No Reason For Excitement

We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

Oct 25
We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

Jun 10
We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

The Market Doesn't Like What It Sees From ADMA Biologics, Inc.'s (NASDAQ:ADMA) Revenues Yet

May 12
The Market Doesn't Like What It Sees From ADMA Biologics, Inc.'s (NASDAQ:ADMA) Revenues Yet

ADMA Biologics: Strong Growth Is Clearing The Path To Profitability

Aug 21

ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M

Aug 10

ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

Jun 01
ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

ADMA Biologics: A Path To Profits Looks Clear

May 12

ADMA: Pertinent Updates

Apr 18

ADMA Biologics' 2021 Numbers Showed Continued Strong Execution

Mar 29

ADMA Biologics: 2021 Was Tough

Jan 18

ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

Dec 02
ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

ADMA Biologics: Turning A Corner

Nov 20

ADMA: Insiders Showing Their Cards

Nov 02

ADMA Biologics: Recent Significant Developments And Their Implications For The Stock

Aug 22

ADMA Biologics: Feeling Bullish After Encouraging Q2 Earnings Report

Aug 14

CEO報酬分析

ADMA Biologics の収益と比較して、Adam Grossman の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$6mUS$750k

-US$28m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$40m

Mar 31 2023n/an/a

-US$48m

Dec 31 2022US$3mUS$637k

-US$66m

Sep 30 2022n/an/a

-US$70m

Jun 30 2022n/an/a

-US$73m

Mar 31 2022n/an/a

-US$78m

Dec 31 2021US$4mUS$618k

-US$72m

Sep 30 2021n/an/a

-US$74m

Jun 30 2021n/an/a

-US$74m

Mar 31 2021n/an/a

-US$75m

Dec 31 2020US$2mUS$600k

-US$76m

Sep 30 2020n/an/a

-US$67m

Jun 30 2020n/an/a

-US$61m

Mar 31 2020n/an/a

-US$54m

Dec 31 2019US$2mUS$536k

-US$48m

Sep 30 2019n/an/a

-US$56m

Jun 30 2019n/an/a

-US$59m

Mar 31 2019n/an/a

-US$61m

Dec 31 2018US$2mUS$536k

-US$66m

Sep 30 2018n/an/a

-US$61m

Jun 30 2018n/an/a

-US$61m

Mar 31 2018n/an/a

-US$55m

Dec 31 2017US$3mUS$494k

-US$44m

報酬と市場: Adamの 総報酬 ($USD 6.04M ) は、 US市場 ($USD 6.82M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Adamの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Adam Grossman (47 yo)

17.4yrs

在職期間

US$6,039,649

報酬

Mr. Adam S. Grossman serves as Director at BioFlorida Inc since August 2021. He is the Co-Founder of ADMA Biologics, Inc. and has been its Chief Executive Officer and President since October 2011 and 2007...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Adam Grossman
Co-Founder17.4yrsUS$6.04m1.3%
$ 32.1m
Jerrold Grossman
Co-Founder & Vice Chairman of the Board17.4yrsUS$284.72k0.21%
$ 5.3m
Kaitlin Kestenberg
COO & Senior VP of Complianceless than a yearデータなし0.048%
$ 1.2m
Drew Pantello
Vice President of Marketing & Corporate Developmentno dataデータなしデータなし
Cindy Petersen
Executive Director of Human Resources2.4yrsデータなしデータなし
Skyler Bloom
Senior Director of Business Development & Corporate Strategyno dataデータなしデータなし
Brad Tade
Vice President of Financial Operationsless than a yearデータなしデータなし

1.7yrs

平均在職期間

47yo

平均年齢

経験豊富な経営陣: ADMAの経営陣は 経験豊富 とはみなされません ( 1.7年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称ポジション在職期間報酬所有権
Adam Grossman
Co-Founder17.4yrsUS$6.04m1.3%
$ 32.1m
Jerrold Grossman
Co-Founder & Vice Chairman of the Board17.4yrsUS$284.72k0.21%
$ 5.3m
Bryant Fong
Independent Director12.1yrsUS$280.72k0.026%
$ 636.7k
Steven Elms
Independent Chairman17.4yrsUS$290.22k0.023%
$ 557.1k
Young Kwon
Independent Director2.7yrsUS$272.34k0.12%
$ 2.9m
Michael Green
Member of Scientific Advisory Boardno dataデータなしデータなし
Lawrence Guiheen
Independent Director11.9yrsUS$275.09k0.056%
$ 1.4m
Roy Chemaly
Member of Scientific Advisory Board10yrsデータなしデータなし
Jordan Orange
Member of Scientific Advisory Board10yrsデータなしデータなし
Alison Finger
Independent Directorless than a yearUS$231.12kデータなし
Jean-Laurent Casanova
Member of Scientific Advisory Boardno dataデータなしデータなし
Ann Falsey
Member of Scientific Advisory Boardno dataデータなしデータなし

11.9yrs

平均在職期間

59yo

平均年齢

経験豊富なボード: ADMAの 取締役会 は経験豊富で 経験豊富 です ( 11.9年の平均在任期間)。